Science Explorer Back to mapMap
Discussion
Researcher · Hematology Oncology Consultants · United States

Leslie Rogers Laufman

Leslie Rogers Laufman publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations and Colorectal Cancer Treatments and Studies.

OpenAlex
World rank
#2,064,877
of 7,710,434 ranked researchers
Rank in United States
#624,545
of 1,627,098
Works
55
Citations
2.3k
Citations per work
41.9
h-index
21
i10-index 28Top 22% in Oncology
Leslie Rogers Laufman

What does Leslie Rogers Laufman research?

Leslie Rogers Laufman's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 35 works · 64.4% of their workMedicine: 35 works · 64.4% of their workOncology: 18 works · 33.6% of their workPulmonary and Respiratory Medicine: 10 works · 17.4% of their workSurgery: 5 works · 8.7% of their workHematology: 3 works · 4.7% of their workEverything else: 15 works · 27.5% of their workLife Sciences: 4 works · 8.1% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 8.1% of their workCancer Research: 3 works · 4.7% of their workGenetics: 2 works · 3.4% of their workTHEIR WORKLeslie RogersLaufman55works
Life Sciences8%Health Sciences64%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3564.4%
  2. Everything else1527.5%
    1. Biochemistry, Genetics and Molecular Biology48.1%
  1. 1Oncology34% of their works
  2. 2Pulmonary and Respiratory Medicine17% of their works
  3. 3Surgery9% of their works
  4. 4Cancer Research5% of their works
  5. 5Hematology5% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Leslie Rogers Laufman's research?

The keywords of their largest research topics: Chemotherapy, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Clinical Trials, Targeted Therapy, Molecular Subtypes, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Chemotherapy305 topics
  2. Chemotherapy-Induced Peripheral Neuropathy161 topic
  3. Taxanes161 topic
  4. Clinical Trials152 topics
  5. Targeted Therapy152 topics
  6. Molecular Subtypes122 topics
  7. ALK Inhibitors91 topic
  8. EGFR Mutations91 topic
  9. Cetuximab81 topic
  10. Clinical Practice Guidelines82 topics
  11. KRAS Mutations81 topic
  12. Survival Analysis82 topics
  13. Antimicrobial Agents71 topic
  14. Febrile Neutropenia71 topic
  15. Genomic Profiles61 topic
  16. Small-Cell Lung Cancer61 topic
  17. Dermatological Toxicity51 topic
  18. Extravasation51 topic
  19. Breast Tumours41 topic
  20. Endoscopic Resection41 topic
  21. Gastric Cancer41 topic
  22. Gene Expression41 topic

Where does Leslie Rogers Laufman work?

Leslie Rogers Laufman's main affiliation in the publication record is Hematology Oncology Consultants, United States.

How many publications and citations does Leslie Rogers Laufman have?

OpenAlex counts 55 works and 2,302 citations for Leslie Rogers Laufman, an h-index of 21, ranking #2,064,877 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Leslie Rogers Laufman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.